Transgenic NADH dehydrogenase restores oxygen regulation of breathing in mitochondrial complex I-deficient mice.
Blanca Jiménez-GómezPatricia Ortega-SáenzLin GaoPatricia González-RodríguezPaula García-FloresNavdeep S ChandelJosé López-BarneoPublished in: Nature communications (2023)
The hypoxic ventilatory response (HVR) is a life-saving reflex, triggered by the activation of chemoreceptor glomus cells in the carotid body (CB) connected with the brainstem respiratory center. The molecular mechanisms underlying glomus cell acute oxygen (O 2 ) sensing are unclear. Genetic disruption of mitochondrial complex I (MCI) selectively abolishes the HVR and glomus cell responsiveness to hypoxia. However, it is unknown what functions of MCI (metabolic, proton transport, or signaling) are essential for O 2 sensing. Here we show that transgenic mitochondrial expression of NDI1, a single-molecule yeast NADH/quinone oxidoreductase that does not directly contribute to proton pumping, fully recovers the HVR and glomus cell sensitivity to hypoxia in MCI-deficient mice. Therefore, maintenance of mitochondrial NADH dehydrogenase activity and the electron transport chain are absolutely necessary for O 2 -dependent regulation of breathing. NDI1 expression also rescues other systemic defects caused by MCI deficiency. These data explain the role of MCI in acute O 2 sensing by arterial chemoreceptors and demonstrate the optimal recovery of complex organismal functions by gene therapy.
Keyphrases
- single molecule
- mild cognitive impairment
- oxidative stress
- single cell
- gene therapy
- poor prognosis
- liver failure
- cell therapy
- induced apoptosis
- drug induced
- mouse model
- hepatitis b virus
- atomic force microscopy
- genome wide
- cell cycle arrest
- electronic health record
- cell proliferation
- replacement therapy
- artificial intelligence
- copy number
- saccharomyces cerevisiae